Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month price […]
Canaccord Genuity Group Trims Akero Therapeutics (NASDAQ:AKRO) Target Price to $56.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Akero Therapeutics (NASDAQ:AKRO – Free Report) in a research note released on Monday morning, Benzinga reports. They currently have a $50.00 price objective on the stock. HC Wainwright also issued estimates for Akero Therapeutics’ Q2 2024 earnings at ($0.82) EPS, Q3 2024 earnings at ($0.87) EPS, […]
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by E Fund Management Co. Ltd. kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report)’s share price rose 5.5% on Monday . The stock traded as high as $20.77 and last traded at $20.74. Approximately 65,585 shares changed hands during trading, a decline of 94% from the average daily volume of 1,191,632 shares. The stock had previously closed at $19.66. Analysts Set […]